Cargando…
Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
Acute kidney injury (AKI) following ischemia–reperfusion injury (IRI) has a high mortality and lacks specific therapies. Here, we report that mice lacking kynurenine 3-monooxygenase (KMO) activity (Kmo(null) mice) are protected against AKI after renal IRI. We show that KMO is highly expressed in the...
Autores principales: | Zheng, Xiaozhong, Zhang, Ailiang, Binnie, Margaret, McGuire, Kris, Webster, Scott P., Hughes, Jeremy, Howie, Sarah E. M., Mole, Damian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374422/ https://www.ncbi.nlm.nih.gov/pubmed/30760699 http://dx.doi.org/10.1038/s12276-019-0210-x |
Ejemplares similares
-
Diclofenac Identified as a Kynurenine 3-Monooxygenase
Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018) -
Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016) -
Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
por: Wilson, K., et al.
Publicado: (2014) -
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022) -
Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback
por: Wilson, K, et al.
Publicado: (2016)